Provider QP90-18 Addition of Drugs to the Self-Administered Oncology Agents Prior Authorization with Quantity Limit Program Read More
Provider QP69-18 Universal Pharmacy Policy for Minnesota Health Care Programs Subscribers - Morphine Equivalent Dose (MED) Limit Update Read More
Provider QP93-18 Technical Issues with Authorization and Referral Tool on Availity Resolved Read More
Provider QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program Read More
Provider QP58-18 Pharmacy Benefit Exclusion for Cytovene, Foscavir, Prevymis, Trogarzo, Vistide and Zovirax Read More
Provider QP65-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Jynarque (tolvapin) Read More
